Renal disease | Number of patients with percentage (in category) | Up to 18 years | 19–39 years | 40 years and above |
---|---|---|---|---|
Primary glomerular disease | 61 | 12 | 21 | 28 |
1.MN | 14 (22.9%) | 1 | 7 | 6 |
2. MCD | 10 (16.3%) | 3 | 4 | 3 |
3.MPGN | 11 (18%) | 0 | 5 | 6 |
4. FSGN | 9 (14.7%) | 3 | 3 | 3 |
5.C3 GN | 2 (3.2%) | 2 | 0 | 0 |
6.Cresentric GN | 2 (3.2%) | 0 | 0 | 2 |
7. DPGN | 1 (1.6%) | 0 | 0 | 1 |
8.IgA nephropathy | 8 (13.1%) | 1 | 2 | 5 |
9. Anti-GBM | 2 (3.2%) | 0 | 0 | 2 |
10.Alport syndrome | 1 (1.6%) | 1 | 0 | 0 |
11.MGN | 1 (1.6%) | 1 | 0 | 0 |
Secondary glomerular disease | 23 | 4 | 3 | 16 |
1.DN | 10 (43.4%) | 0 | 0 | 10 |
2.LN | 7 (30.4%) | 4 | 3 | 0 |
3.CN | 6 (26%) | 0 | 0 | 6 |
Tubulo-interstitial disease | 20 | 2 | 6 | 12 |
1. TIN | 8 (40%) | 1 | 4 | 7 |
2. Pyelonephritis | 4 (20%) | 1 | 0 | 3 |
3. ATN | 4 (20%) | 0 | 0 | 1 |
4. ACN | 4 (20%) | 0 | 2 | 1 |
Vascular disease | 2 | 0 | 0 | 2 |
TMA | 2 (100%) | 0 | 0 | 2 |